Skip to main content
OpenTrials
Completed

NCT Number: NCT02682186

Pectoral Nerve Block for Analgesia After Breast Augmentation

Breast augmentation is among the most popular surgical procedures performed in the world with approximately 1,773,584 performed in 2013. This surgical intervention generates important pains during postsurgical recovery. A multimodal analgesia, based on the recommendations is proposed to the patients .The pectoral nerve block is an innovative technique of locoregional anesthesia that has already been successfully used in breast surgery. Its realization is fast, simple, and it would be superior compared with a paravertebral block within the framework of mastectomy. The interest of this technique has never been assessed in esthetic breast surgery. The aim of this study is to evaluate the analgesic efficacy of the association of " Pecs blocks 1 and 2 " on pain intensity after breast augmentation surgery.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Ambulatory Plastic Surgery Esthetic Prosthetic Breast Expansion Neurologic Manifestations Pain Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

18 year–70 year

Sex eligibility

Female

Study type

Interventional

Phase

Phase 3

Primary location

CHU Nîmes, Nîmes, France

Loading trial locations.

About this study

The investigators hypothesized that the "Pecs blocks 1 and 2" will provide a decrease of the maximal pain of the first 6 post-operative hours after prosthetic breast expansion. The pain will be assessed according to a numerical scale. This prospective, randomized, double blind study will include 92 patients successively during two years, randomized into two arms : Pecs group and Control group, which will respectively have the block, and no block. The rest of the anesthesic and surgical care will be identical.

An intervention team (which will be different from the anesthesic team), will be alone with the patient for 15 minutes, and will realize or not the Pecs blocks according to the previous randomisation so that all caregivers taking in charge the patients as well as research observers will be blinded.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Affiliated to a national insurance scheme
  • Having signed the informed consent for this study
  • Score of American Society of Anesthesiology ( ASA) 1-3
  • Be hospitalized in the ambulatory care unit (UCA) or plastic surgery service for a scheduled esthetic prosthetic breast expansion surgery.

Exclusion criteria

  • Protected minor or major patients or in the incapacity to give his consent according to the article L1121-8 of the Code of the Health Public.
  • Pregnant or breast-feeding women according to French law.
  • Vulnerable people.
  • Patients participating in another research
  • Allergy with local anesthetics.
  • Severe coagulopathy.
  • Chronic painful Patients (long-term treatment by analgesics)
  • Contraindication to use analgesics of the protocol.
  • Change of breast prostheses

Treatment and study plan

Ropivacaine after dilution with sodium chloride 0.9%

Drug

After the anesthesic induction, the interventional team composed by at least a senior anaesthesiologist and a nurse anesthestic, will survey the patient and perform the Pecs blocks, whereas the anesthetic team is outside the room.

Realization of Pecs blocks 1 and 2 : the patient is in supine position with placing the upper limb in abduction position, a 100 mm needle is inserted under ultrasound using a linear US probe of high frequency after sheathing.

In the other group, sterilization, sheating and US are performed but the needle is not inserted.

Primary outcomes

  1. Maximal value of pain intensity according to the numerical scale within the six first hours

    Time frame: up to First six postoperative hours

Secondary outcomes

  1. Maximal value of the pain at day 1 and until day 5

    Time frame: Five days

    Value of pain according to a Numeric scale , recorded at day 1 in the hospital, and until day five by phone interview.

  2. Morphinics side effects such as nausea / vomiting, constipation, pruritus; analgesic consumption, surgical complication, satisfaction questionaire

    Time frame: Five days

    Any of side effect

Sponsors and collaborators

Lead sponsor

University Hospital, Montpellier

Other

Registry information

Official study title

Effects of the Pectoral Blocks in the Prosthetic Breast Expansion Surgery : Prospective, Randomized, Double Blind Study.

Acronym: PECS B&BS

Important dates

Study start
2016
Primary completion
2019
Study completion
2020
First posted
Feb 15, 2016
Registry last updated
Jun 12, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.